Empowering Natural Tissue Regeneration
Empowering Natural Tissue Regeneration

Bone specialist Osteopore (ASX:OSX) has signed a Memorandum of Understanding (MOU) with China-based medical device innovation accelerator InnoVentures to commercialise Osteopore’s orthopaedic products in China.

Are you a Healthcare Professional?

The content of the Healthcare Professional pages is intended for a medical specialist audience only.
By using this site or downloading materials from the site, you agree to abide by the terms and conditions set forth in our Privacy Policy and Legal Notice.

No, I am not a Healthcare professional. Please take me to the Patient Care content, or the Homepage.